Bimodality Versus Trimodality Treatment Approaches in Stage lllA Nonsmall Cell Lung Cancer – Where Do We Stand?

Bimodality Versus Trimodality Treatment Approaches in Stage lllA Nonsmall Cell Lung Cancer – Where Do We Stand? – MM1404

A substantial proportion of patients with nonsmall cell lung cancer (NSCLC) present with locally advanced (ie, stage III) disease. Incidence has been divided between stage IIIA and stage IIIB, with additional, and perhaps more practical,
division was between ‘operable’ and ‘inoperable’ patients.

Modern Medicine – April 2014